For HCPs only.
Cytotect CP® is indicated for prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly transplant recipients.1
The concomitant use of adequate virostatic agents should be considered for CMV prophylaxis.1 Basic Information available here.

Back

Copyright © 2024 Biotest AG. All rights reserved. Biotest AG is proprietor of all trademarks and tradenames used on this website.